The Optimisticc team is supported through the Cancer Grand Challenges initiative. Learn more here

IL-22 Pathway Identified as a New Target in Colon Cancers with Mutant KRAS

August 20, 2020

IL-22 Pathway Identified as a New Target in Colon Cancers with Mutant KRAS

August 20, 2020
;

Work from Dr. Fiona Powrie’s group at University of Oxford has identified an interaction between the receptor for the immune molecule interleukin-22 (IL-22) and alterations of the KRAS gene, showing that they cooperate in promoting excessive proliferation of colon cancer cells. As KRAS mutations are present in almost half of all colorectal tumors and are poorly responsive to standard therapies, these results suggest that patients with a mutant KRAS and high IL-22 receptor levels may benefit from alternative strategies involving IL-22 modulation. This study is published in Clinical Cancer Research and is described in more detail in a University of Oxford press release.

Related Posts

OPTIMISTICC congratulates Dr. Greg Higgins!

OPTIMISTICC congratulates Dr. Greg Higgins!

Congratulations to Greg Higgins, who successfully defended his PhD in December 2023! Greg's work characterized the potential role of unusual predatory bacteria called Bdellovibrio to semi-selectively kill oncomicrobes, such as Fusobacteria, within the gut...

OPTIMISTICC Trainees Attend CGC Future Leaders Conference in Portugal

OPTIMISTICC Trainees Attend CGC Future Leaders Conference in Portugal

From Nov. 1-3, 2023, OPTIMISTICC trainees joined members of other Cancer Grand Challenges Teams in Lisbon, Portugal for the 2023 Future Leaders Conference. Congratulations to Kelsey Thompson, who was awarded first place for her excellent poster, and thank you to our...

Dr. Tomotaka Ugai Receives AICR Investigator-Initiated Research Grant

Dr. Tomotaka Ugai Receives AICR Investigator-Initiated Research Grant

Congratulations to Dr. Tomotaka Ugai for receiving an American Institute for Cancer Research (AICR) Investigator-Initiated Research Grant award for his work entitled "Integration of Immunology and Microbiology into Epidemiologic Research on Early-onset Colorectal...

Optimisticc
Loading...